The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The value of pretreatment 18F-FDG PET/CT to predict the pathological treatment response of hepatocellular carcinoma patients treated with PD-1 inhibitors and lenvatinib as a conversion therapy in BCLC stage C.
 
Guanyun Wang
No Relationships to Disclose
 
Guangyu Ma
No Relationships to Disclose
 
Wenwen Zhang
No Relationships to Disclose
 
Baixuan Xu
No Relationships to Disclose
 
Shichun Lu
No Relationships to Disclose
 
Jiaxin Chen
No Relationships to Disclose
 
Xiaohui Luan
No Relationships to Disclose
 
Zhanbo Wang
No Relationships to Disclose
 
Xiaodan Xu
No Relationships to Disclose
 
Zhiwei Guan
No Relationships to Disclose
 
Shuang Tong
No Relationships to Disclose